BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy
NEW YORK – BostonGene said on Wednesday that it is collaborating with the Little Warrior Foundation to develop liquid biopsy assays for the detecti...
NEW YORK – BostonGene said on Wednesday that it is collaborating with the Little Warrior Foundation to develop liquid biopsy assays for the detection of sarcoma-related molecular alterations and gene fusions. Because broad liquid biopsy panels have limited utility for specific cancer types, BostonGene will focus on sarcoma-specific cell-free DNA and RNA assays tailored to the molecular alterations and fusions found in that cancer with the goal of implementing them in clinical practice for adult and pediatric sarcomas.